For miR-29b delivery to chronic lymphocytic leukemia cells, the oncofetal antigen receptor tyrosine kinase orphan receptor 1 (ROR1) was used for targeting the nanoparticles. The gene discussed is ROR1; the disease is B-cell chronic lymphocytic leukemia.